Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 13, 2026 20:43 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000020 · form4-10132026_081013.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,265 F1 · kind: The disposition of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:07 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000018 · form4-09242026_100921.xml · derivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,904 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on September 23, 2026. F4 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on September 23, 2026. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:07 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000018 · form4-09242026_100921.xml · derivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,448 Underlying: Common Stock · 1,224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on September 23, 2026. F3 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on September 23, 2026. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:07 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,197 | $177.20 | $212,108.40 |
DisclosureSEC source: 0001677721-26-000018 · form4-09242026_100921.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,265 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:07 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 1,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000018 · form4-09242026_100921.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:07 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 1,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000018 · form4-09242026_100921.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:06 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 596 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000012 · form4-09242026_100918.xml · derivative · entry 5 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,580 Underlying: Common Stock · 596 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 9,545 RSUs. One-sixteenth of these vested on September 23, 2026. F4 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 9,545 RSUs. One-sixteenth of these vested on September 23, 2026. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:06 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000012 · form4-09242026_100918.xml · derivative · entry 4 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 959 Underlying: Common Stock · 479 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 7,665 RSUs. One-sixteenth of these vested on September 23, 2026. F3 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 7,665 RSUs. One-sixteenth of these vested on September 23, 2026. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:06 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 424 | $177.20 | $75,132.80 |
DisclosureSEC source: 0001705407-26-000012 · form4-09242026_100918.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,039 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:06 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 596 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000012 · form4-09242026_100918.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 22:06 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 479 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000012 · form4-09242026_100918.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2026 Filed Sep 21, 2026 21:50 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 8,892 | $185.00 | $1,645,020.00 |
DisclosureSEC source: 0001705407-26-000010 · form4-09212026_090952.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,388 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on December 10, 2025. Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 20:31 UTC |
WASHINGTON MIRONDirector
|
SaleCommon Stock | 800 | $173.26 | $138,608.00 |
DisclosureSEC source: 0001969449-26-000004 · form4-09162026_080906.xml · nonDerivative · entry 1 WASHINGTON MIRON · CIK 0001969449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,354 Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 20:47 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000016 · form4-09152026_080948.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 354,421 F1 · kind: The disposition of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 23:10 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000008 · form4-08212026_110853.xml · derivative · entry 3 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,219 Underlying: Common Stock · 1,739 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On August 20, 2025, the reporting person was granted 6,958 RSUs. One-fourth of these vested on August 20, 2026. F3 · derivative.expiration_date: On August 20, 2025, the reporting person was granted 6,958 RSUs. One-fourth of these vested on August 20, 2026. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 23:10 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 685 | $159.73 | $109,415.05 |
DisclosureSEC source: 0001705407-26-000008 · form4-08212026_110853.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,280 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 23:10 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000008 · form4-08212026_110853.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 23:08 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 3,753 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000014 · form4-08212026_110843.xml · derivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,262 Underlying: Common Stock · 3,753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On August 20, 2025, the reporting person was granted 15,015 RSUs. One-fourth of these vested on August 20, 2026. F3 · derivative.expiration_date: On August 20, 2025, the reporting person was granted 15,015 RSUs. One-fourth of these vested on August 20, 2026. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 23:08 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,477 | $159.73 | $235,921.21 |
DisclosureSEC source: 0001677721-26-000014 · form4-08212026_110843.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,421 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 23:08 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 3,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000014 · form4-08212026_110843.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 20:51 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000012 · form4-08182026_080835.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 362,145 F1 · kind: The disposition of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:50 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,429 | $185.00 | $264,365.00 |
DisclosureSEC source: 0001705407-26-000006 · form4-08122026_080857.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,226 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on December 10, 2025. Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 20:36 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000011 · form4-07142026_080705.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 372,145 F1 · kind: The disposition of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:15 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 597 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000004 · form4-06242026_090633.xml · derivative · entry 5 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,176 Underlying: Common Stock · 597 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 9,545 RSUs. One-sixteenth of these vested on June 23, 2026. F4 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 9,545 RSUs. One-sixteenth of these vested on June 23, 2026. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:15 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000004 · form4-06242026_090633.xml · derivative · entry 4 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 479 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 7,665 RSUs. One-sixteenth of these vested on June 23, 2026. F3 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 7,665 RSUs. One-sixteenth of these vested on June 23, 2026. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:15 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 424 | $125.22 | $53,093.28 |
DisclosureSEC source: 0001705407-26-000004 · form4-06242026_090633.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,655 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:15 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 597 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000004 · form4-06242026_090633.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:15 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 479 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000004 · form4-06242026_090633.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:10 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000009 · form4-06242026_090620.xml · derivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,721 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on June 23, 2026. F4 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on June 23, 2026. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:10 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,223 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000009 · form4-06242026_090620.xml · derivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,672 Underlying: Common Stock · 1,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on June 23, 2026. F3 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on June 23, 2026. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:10 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 1,197 | $125.22 | $149,888.34 |
DisclosureSEC source: 0001677721-26-000009 · form4-06242026_090620.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,145 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:10 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 1,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000009 · form4-06242026_090620.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 21:10 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 1,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000009 · form4-06242026_090620.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 21:03 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000007 · form4-06162026_090649.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380,302 F1 · kind: The disposition of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 21:31 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 19,105 | $127.36 | $2,433,168.86 |
DisclosureSEC source: 0002003074-26-000013 · primary_doc.xml · nonDerivative · entry 3 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 775,943 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 21:17 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 12,105 | $127.36 | $1,541,664.96 |
DisclosureSEC source: 0002003074-26-000012 · primary_doc.xml · nonDerivative · entry 3 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 782,943 Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:31 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 33,000 | $130.07 | $4,292,260.50 |
DisclosureSEC source: 0002003074-26-000013 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 795,048 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:31 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 12,528 | $125.97 | $1,578,090.77 |
DisclosureSEC source: 0002003074-26-000013 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 828,048 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:17 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 33,000 | $130.07 | $4,292,260.50 |
DisclosureSEC source: 0002003074-26-000012 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 795,048 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:17 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 12,528 | $125.97 | $1,578,090.77 |
DisclosureSEC source: 0002003074-26-000012 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 828,048 Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:29 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 35,877 | $122.50 | $4,394,943.26 |
DisclosureSEC source: 0002003074-26-000011 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 840,576 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:29 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 11,602 | $128.87 | $1,495,131.18 |
DisclosureSEC source: 0002003074-26-000011 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 876,453 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 21:01 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 33,412 | $136.84 | $4,572,215.02 |
DisclosureSEC source: 0002003074-26-000010 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 888,055 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 21:04 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 6,313 | $139.17 | $878,556.85 |
DisclosureSEC source: 0002003074-26-000009 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 921,467 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 21:04 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 38,724 | $142.31 | $5,510,986.70 |
DisclosureSEC source: 0002003074-26-000009 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 927,780 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 22:02 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 7,163 | $144.29 | $1,033,557.15 |
DisclosureSEC source: 0002003074-26-000008 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 966,504 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 22:02 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 48,504 | $150.78 | $7,313,214.85 |
DisclosureSEC source: 0002003074-26-000008 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 973,667 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:36 UTC |
Gibson Daniel PatrickDirector
|
GrantRestricted Stock Units · Derivative | 1,896 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001745725-26-000002 · form4-05292026_090520.xml · derivative · entry 4 Gibson Daniel Patrick · CIK 0001745725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,896 Underlying: Common Stock · 1,896 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: The restricted stock units will fully vest on May 28, 2027. F4 · derivative.expiration_date: The restricted stock units will fully vest on May 28, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:36 UTC |
Gibson Daniel PatrickDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001745725-26-000002 · form4-05292026_090520.xml · derivative · entry 3 Gibson Daniel Patrick · CIK 0001745725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On June 5, 2025, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. F3 · derivative.expiration_date: On June 5, 2025, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:36 UTC |
Gibson Daniel PatrickDirector
|
Exercise / conversionCommon Stock | 3,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001745725-26-000002 · form4-05292026_090520.xml · nonDerivative · entry 1 Gibson Daniel Patrick · CIK 0001745725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.